 |
|
|
| |
Effects of the HIV-1 Maturation Inhibitor
GSK3640254 on QT Interval in Healthy Participants
|
| |
| |
HIV Drug Therapy Glasgow; October 23-26, 2022; Virtual and Glasgow, Scotland
Ying Zhang,1 Mark Johnson,2 Mark Bush,2 Parto Yazdani,3 Joyce Zhan,1 Bo Wen,1 Veronica Bainbridge,4 Brian Wynne,2 Samit Joshi,5 Max Lataillade5
1GSK, Collegeville, PA, USA; 2ViiV Healthcare, Durham, NC, USA; 3GSK, Mississauga, Ontario, Canada; 4GSK, Brentford, UK; 5ViiV Healthcare, Branford, CT, USA
|
| |
|
|
|
|
|
